| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/27/2001 | CA2025598C Chimaeric hepadnavirus core antigen proteins |
| 02/27/2001 | CA1341191C Detection of neu gene expression and products |
| 02/22/2001 | WO2001012812A2 Baff receptor (bcma), an immunoregulatory agent |
| 02/22/2001 | WO2001012806A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | WO2001012673A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | WO2001012663A2 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | WO2001012215A2 Protective antigen of epstein barr virus |
| 02/22/2001 | WO2000036107A3 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 02/22/2001 | WO1999056771A3 Methods of raising animals for meat production |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
| 02/22/2001 | CA2464845A1 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | CA2383154A1 Baff receptor (bcma), an immunoregulatory agent |
| 02/22/2001 | CA2381979A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | CA2381712A1 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | CA2380991A1 Protective antigen of epstein barr virus |
| 02/21/2001 | EP1076703A2 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/21/2001 | EP1076666A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
| 02/21/2001 | EP1076662A2 Polyepitope carrier protein |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/21/2001 | EP0526452B1 Hybrid immunoglobulins |
| 02/21/2001 | CN1284999A Maize H3C4 promoter associated with first rice actin intron, chimeric gene containing it and transformed plant |
| 02/21/2001 | CN1284885A Vaccine |
| 02/21/2001 | CN1284884A 疫苗 Vaccine |
| 02/20/2001 | US6191113 Peptide for inhibiting growth of smooth muscle cells |
| 02/20/2001 | US6190886 Trimerizing polypeptides, their manufacture and use |
| 02/20/2001 | US6190880 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 02/20/2001 | US6190876 KUZ, a novel family of metalloproteases |
| 02/20/2001 | US6190873 Mixing in aqueous medium the sample, a cyclosporin-label conjugate having specific linking groups, and antibodies capable of binding to cyclosporin-label conjugate; and determining presence of complex |
| 02/20/2001 | US6190871 Determining efficacy of monoclonal antibody to neutralize primary isolates by culturing various concentrations of antibody with virus and h9 cells, determining concentration of p24 antigen as indicator of infection, and comparing |
| 02/15/2001 | WO2001011056A1 Production of proteins by autoproteolytic cleavage |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001010912A1 Multiple cytokine-antibody complexes |
| 02/15/2001 | WO2000068376B1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/15/2001 | WO2000049416A3 Receptor assay for detecting an effect test compounds have on a particular membrane receptor |
| 02/15/2001 | WO2000044908A3 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/15/2001 | CA2380302A1 Production of proteins by autoproteolytic cleavage |
| 02/14/2001 | EP1075496A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 02/14/2001 | EP1075492A1 Melanocortin 1 receptor selective compounds |
| 02/14/2001 | CN1284134A Methods of producing anti-angiogenic proteins: endostation, angiostation or restin, using pichia yeast expression system |
| 02/14/2001 | CN1284131A Human tyroid protein ZSIG45 and data encoding same |
| 02/14/2001 | CN1284130A Mutants of endostation, 'EM1' having ant-angiogenic activety and methods of use thereof |
| 02/13/2001 | US6187748 Treatment and prevention of hiv |
| 02/13/2001 | US6187564 Nucleotide sequences coding a fusion protein; for the proliferation, differentiation and activation of hematopoietic stem cells; for treatment of cancers; anticarcinogenic agents |
| 02/13/2001 | US6187308 Ameliorating an immune response disorder. |
| 02/10/2001 | WO2001032871A2 Follistatin-related protein zfsta4 |
| 02/10/2001 | CA2389956A1 Follistatin-related protein zfsta4 |
| 02/08/2001 | WO2001009334A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009313A1 G-protein coupled receptor and dna sequences thereof |
| 02/08/2001 | WO2001009291A1 Attenuated influenza virus useful as vaccine |
| 02/08/2001 | WO2001009193A1 Chimeric polypeptides, method for production and uses thereof |
| 02/08/2001 | WO2001009192A1 Human monoclonal antibodies to prostate specific membrane antigen |
| 02/08/2001 | WO2001009187A2 Human monoclonal antibodies to her2/neu |
| 02/08/2001 | WO2001009186A2 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 02/08/2001 | WO2001009179A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 02/08/2001 | WO2001009170A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/08/2001 | WO2001008636A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 02/08/2001 | WO2000075317A3 Compositions and methods for the treatment of tumor |
| 02/08/2001 | WO2000069456A3 Adjuvant combination formulations |
| 02/08/2001 | WO2000061756A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 02/08/2001 | CA2381565A1 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 02/08/2001 | CA2381437A1 G-protein coupled receptor and dna sequences thereof |
| 02/08/2001 | CA2380813A1 Human monoclonal antibodies to her2/neu |
| 02/08/2001 | CA2380803A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | CA2380514A1 Attenuated influenza virus useful as vaccine |
| 02/08/2001 | CA2380428A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/08/2001 | CA2380295A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 02/07/2001 | EP1074563A1 Chimeric polypeptides enhancing dimer formation through electrostatic interactions and disulfide bond, method for production and uses thereof |
| 02/07/2001 | EP1073763A1 Methods for transducing fusion molecules |
| 02/07/2001 | EP1073758A1 Retroviral vectors including modified envelope escort proteins |
| 02/07/2001 | EP1073750A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 02/07/2001 | EP1073748A2 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis |
| 02/07/2001 | EP1073724A1 Laundry detergent and/or fabric care compositions comprising a modified enzyme |
| 02/07/2001 | EP1073684A1 Fabric care compositions comprising cellulose binding domains |
| 02/07/2001 | EP1073465A1 T cell inhibitory receptor compositions and uses thereof |
| 02/06/2001 | US6184032 Identification of genes encoding cell surface antigens using CREF-Trans 6 cells |
| 02/06/2001 | US6184013 Antibody for reducing concentration of drug in patient |
| 02/06/2001 | US6183754 Anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses and a protein-kinase inducible by cytomegaloviruses and recognizable by aforesaid monoclonal antibodies |
| 02/06/2001 | CA2125467C Process for producing hydrophobic polypeptides, proteins or peptides |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/06/2001 | CA2075974C Totally synthetic affinity reagents |
| 02/06/2001 | CA2067744C The human c3b/c4b receptor (cr1) |
| 02/01/2001 | WO2001007616A1 Polynucleotide encoding autoantigens associated with endometriosis |
| 02/01/2001 | WO2001007477A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007081A1 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 02/01/2001 | WO2000066722B1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | WO1999041376A9 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/01/2001 | WO1997045137A8 Methods and compositions useful for inhibition of angiogenesis |
| 02/01/2001 | DE10031839A1 Erythropoietinkonjugate Erythropoietinkonjugate |
| 02/01/2001 | CA2380037A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 01/31/2001 | EP1071952A1 I kappa b and enhanced green fluorescent fusion protein |
| 01/31/2001 | EP1071780A1 Soluble protein ztmpo-1 |
| 01/31/2001 | EP1071779A1 Vertebrate patched-2 protein |
| 01/31/2001 | EP1071774A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 01/31/2001 | EP1071773A1 Sh2 domain-containing peptides |
| 01/31/2001 | EP1071767A1 Gene coding for heliomicine and use thereof |
| 01/31/2001 | EP1071763A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |